Roche’s Avastin Misses Prostate-Cancer Goal – Wall Street Journal
![]() Insciences Organisation |
Roche's Avastin Misses Prostate-Cancer Goal
Wall Street Journal ZURICH—Roche Holding AG said Friday its best-selling cancer drug Avastin failed in a late-stage prostate cancer trial, undermining market … Roche's Avastin fails in prostate cancer studyReuters Roche: prostate cancer study didn't meet objectiveMarketWatch Roche Needs Boost After Avastin Fails In Prostate Cancer TrialWall Street Journal (blog) Forbes -Trading Markets (press release) -Pharma Times all 52 news articles » |









